Italy· 039655016
PROLIZIP*6 cpr rivestite 500 mg
A cefprozil product containing cefprozil, registered in Italy by FARTO Srl, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Cefprozil is registered in 6 of 19 countries.
Countries holding a registration under ATC J01DC10 (cefprozil), each read from that country’s own register.
- This record: Italy
- 4 of them publish a price we can compare per daily dose
Cefprozil · ATC J01DC10
6 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Italyprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefprozil costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- Italy: $3.28 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Cefprozil · price per daily dose (1 g)
USD · FX 28 Sept 2026
- IT Italy$3.28
The record
At a glance
- Active substance
- Cefprozil
- Manufacturer
- FARTO Srl
- Country
- Italy (IT)
- ATC code
- J01DC10
- ATC class
- Cefprozil
- Defined daily dose
- 1 g, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic039655016PROLIZIP*6 cpr rivestite 500 mgEUR 8.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for cefprozil.
Graded by severity as the source publishes them — 21 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefprozil · interactions on record
81 records
- 21 moderate
- 60 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefprozil in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCefprozilAscend Laboratories, LLC
- CzechiaCEFZILBausch Health Ireland Limited, Dublin
- CanadaAURO-CEFPROZILAURO PHARMA INC
- FinlandProcefBristol-Myers Squibb Ab
- United KingdomCefzil 250mg tabletsBristol-Myers Squibb Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Профикс, Цефзил
- Czechia · Cefzil, Cefzil O.S.
- Estonia · Cefzil
- Greece · Cefgram, Cefpro
- Hungary · Cefzil
- Lithuania · Cefzil
- Latvia · Cefzil
- Portugal · Procef
- Slovenia · Cefzil
- Slovakia · Cefzil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/047300ac-fcfe-44dd-9605-d4f9cd792b98 GET /v1/drugs/047300ac-fcfe-44dd-9605-d4f9cd792b98?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 8.65,
"source": "aifa",
"currency": "EUR",
"strength": "CEFPROZIL 500MG 6 UNITA' USO ORALE",
"substance": "Cefprozil",
"equivalence_group": "IZB",
"transparency_flag": null
}See everything about cefprozil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.